miRNA Sequencing and Assays

A Global Strategic Business Report

MCP32187

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

6953

EXECUTIVE POOL

5850

PRICE

817

EXPERT INPUTS

27

COMPANIES

408

DATA TABLES

465

PAGES

2

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (55)

3

CXO

5

VICE PRESIDENT

10

DIRECTOR

25

MANAGER

12

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global miRNA Sequencing and Assays Market to Reach US$763.1 Million by 2030

The global market for miRNA Sequencing and Assays estimated at US$379.0 Million in the year 2024, is expected to reach US$763.1 Million by 2030, growing at a CAGR of 12.4% over the analysis period 2024-2030. miRNA Sequencing & Assay Products, one of the segments analyzed in the report, is expected to record a 11.9% CAGR and reach US$603.5 Million by the end of the analysis period. Growth in the miRNA Sequencing & Assay Services segment is estimated at 14.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$103.3 Million While China is Forecast to Grow at 16.5% CAGR

The miRNA Sequencing and Assays market in the U.S. is estimated at US$103.3 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$159.5 Million by the year 2030 trailing a CAGR of 16.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.1% and 11.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.

Global miRNA Sequencing and Assays Market - Key Trends & Drivers Summarized

Why Is miRNA Sequencing Gaining Unprecedented Attention in Biomedical Research?

MicroRNA (miRNA) sequencing has emerged as a critical tool in understanding gene regulation and its implications in various diseases. With the rise in complex diseases such as cancer, neurodegenerative disorders, and cardiovascular conditions, researchers are increasingly turning to miRNA profiling to identify biomarkers and therapeutic targets. The ability of miRNAs to regulate gene expression and play a role in cellular processes makes them invaluable in precision medicine. The growing investment in genomics and advancements in next-generation sequencing (NGS) technologies have further fueled the adoption of miRNA sequencing. Moreover, public and private initiatives to fund life sciences research are accelerating the development of cutting-edge miRNA assay technologies. The increasing interest in personalized medicine is also contributing to the demand, as miRNA sequencing provides the precision and specificity required to tailor treatments.

How Are Technological Advancements Revolutionizing the miRNA Assays Market?

The miRNA assays market is undergoing a technological transformation, driven by innovations in sequencing platforms and bioinformatics tools. Advanced sequencing technologies, such as single-cell RNA sequencing, are enabling researchers to obtain more detailed insights into miRNA expression and its role in disease pathways. Additionally, the integration of artificial intelligence and machine learning in data analysis has simplified the interpretation of complex miRNA datasets, making the technology more accessible to researchers and clinicians. Innovations in assay kits, including higher sensitivity and specificity, have enhanced the reliability of miRNA detection. Furthermore, the development of multiplexed assays that can simultaneously analyze multiple miRNAs has significantly reduced the cost and time associated with large-scale studies. These advancements not only improve the overall efficiency of miRNA analysis but also broaden its applicability in diagnostics, drug discovery, and therapeutic development.

What Role Do Healthcare Applications Play in Expanding the Market?

The application of miRNA sequencing in healthcare is a major driver of its market expansion. In oncology, for instance, miRNA profiling is being used to develop diagnostic tests that can detect cancer at an early stage, predict patient outcomes, and monitor disease progression. Similarly, in neurology, miRNAs are being investigated as biomarkers for Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions. In addition to diagnostics, miRNA assays are gaining traction in therapeutics, with numerous clinical trials exploring their use in targeted treatments. The integration of miRNA sequencing in prenatal screening, infectious disease diagnostics, and immune response monitoring further demonstrates its versatility. The increasing prevalence of chronic diseases and the global focus on early detection and precision medicine are expected to sustain the demand for miRNA sequencing and assays in the healthcare sector.

What Is Driving Growth in the miRNA Sequencing and Assays Market?

The growth in the miRNA sequencing and assays market is driven by several factors that underscore its pivotal role in advancing biomedical research and healthcare. The rising prevalence of cancer and chronic diseases has significantly increased the demand for miRNA-based diagnostics and therapeutics. Advancements in NGS technologies have made miRNA sequencing more accurate, cost-effective, and widely accessible, further fueling market adoption. The growing focus on personalized medicine and the increasing integration of miRNA profiling in drug discovery pipelines are also key contributors. Moreover, the expanding application of miRNAs in non-invasive liquid biopsies and their role in understanding disease mechanisms have boosted their relevance in modern medicine. Together, these drivers are propelling the miRNA sequencing and assays market toward robust growth, reshaping the landscape of genomic research and clinical practice.

SCOPE OF STUDY

The report analyzes the miRNA Sequencing and Assays market by the following Segments, and Geographic Regions/Countries:

Segments:

Product & Service (miRNA Sequencing & Assay Products, miRNA Sequencing & Assay Services); Technology (Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology, Single Molecule Real-time (SMRT) Sequencing Technology); Application (Cancer Application, Polyglutamine Diseases Application, Autoimmune Diseases Application, Schizophrenia Application, Other Applications); End-Use (Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use, Other End-Uses).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..

SELECT PLAYERS

Abcam Plc; HTG Molecular Diagnostics, Inc.; Illumina, Inc.; Lexogen; Meridian Bioscience, Inc.; New England Biolabs, Inc.; Norgen Biotek Corp.; QIAGEN NV; System Biosciences, LLC; Takara Bio Inc

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy

How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind

Economic Frontiers: Trends, Trials & Transformations

miRNA Sequencing and Assays – Global Key Competitors Percentage Market Share in 2024 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 27 Players Worldwide in 2024 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Advancements in Next-Generation Sequencing Technologies Drive miRNA Analysis Growth

Rising Research Activities in Cancer and Genetic Disorders Propel miRNA Sequencing Demand

Increasing Use of miRNA Sequencing in Biomarker Discovery Drives Market Expansion

Growth in Personalized Medicine Fuels Demand for miRNA Assays

Role of miRNA in Early Diagnosis of Diseases Boosts Market Adoption

Rising Applications of miRNA Sequencing in Drug Development Drive Innovation

Emergence of Cost-Effective miRNA Sequencing Platforms Expands Accessibility

Integration of AI in miRNA Analysis Enhances Research Efficiency

Demand for High-Throughput Screening Technologies Propels miRNA Sequencing Market

Rising Focus on Non-Invasive Diagnostic Techniques Drives Adoption of miRNA Assays

Government and Private Funding for Genomic Research Fuels Market Growth

Expansion of miRNA Applications in Neurological and Cardiovascular Disorders Propels Demand

4. GLOBAL MARKET PERSPECTIVE

World miRNA Sequencing and Assays Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

World Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for miRNA Sequencing and Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for miRNA Sequencing and Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for miRNA Sequencing & Assay Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for miRNA Sequencing & Assay Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for miRNA Sequencing & Assay Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for miRNA Sequencing & Assay Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for miRNA Sequencing & Assay Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for miRNA Sequencing & Assay Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Autoimmune Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Autoimmune Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Autoimmune Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Schizophrenia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Schizophrenia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Schizophrenia Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Polyglutamine Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Polyglutamine Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Polyglutamine Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Research & Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Research & Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Research & Academic Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Sequencing by Synthesis Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Sequencing by Synthesis Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Sequencing by Synthesis Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Nanopore Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Nanopore Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Nanopore Sequencing Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Sanger Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Sanger Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Sanger Sequencing Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Single Molecule Real-time (SMRT) Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Single Molecule Real-time (SMRT) Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Single Molecule Real-time (SMRT) Sequencing Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

miRNA Sequencing and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

USA Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

USA Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

USA Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Canada Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Canada Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Canada Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

JAPAN

miRNA Sequencing and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Japan Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Japan Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Japan Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

CHINA

miRNA Sequencing and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

China Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

China Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

China Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

EUROPE

miRNA Sequencing and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

Europe Historic Review for miRNA Sequencing and Assays by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for miRNA Sequencing and Assays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

FRANCE

miRNA Sequencing and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

France Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

France Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

France Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

GERMANY

miRNA Sequencing and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Germany Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Germany Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Germany Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Italy Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Italy Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Italy Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

UNITED KINGDOM

miRNA Sequencing and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

UK Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

UK Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

UK Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

SPAIN

Spain Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Spain Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Spain Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Spain Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Spain Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Spain Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Spain Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Spain Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

RUSSIA

Russia Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Russia Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Russia Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Russia Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Russia Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Russia Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Russia Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Russia Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

ASIA-PACIFIC

miRNA Sequencing and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for miRNA Sequencing and Assays by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for miRNA Sequencing and Assays by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

AUSTRALIA

miRNA Sequencing and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)

Australia Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Australia Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Australia Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Australia Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Australia Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Australia Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Australia Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Australia Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

INDIA

miRNA Sequencing and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)

India Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

India Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

India Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

India Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

India Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

India Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

India Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

India Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

SOUTH KOREA

South Korea Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

REST OF ASIA-PACIFIC

Rest of Asia-Pacific Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

LATIN AMERICA

miRNA Sequencing and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)

Latin America Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

Latin America Historic Review for miRNA Sequencing and Assays by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for miRNA Sequencing and Assays by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

ARGENTINA

Argentina Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

BRAZIL

Brazil Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

MEXICO

Mexico Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

REST OF LATIN AMERICA

Rest of Latin America Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

MIDDLE EAST

miRNA Sequencing and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)

Middle East Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

Middle East Historic Review for miRNA Sequencing and Assays by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for miRNA Sequencing and Assays by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

IRAN

Iran Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Iran Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Iran Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Iran Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Iran Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Iran Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Iran Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Iran Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

ISRAEL

Israel Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Israel Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Israel Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Israel Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Israel Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Israel Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Israel Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Israel Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

SAUDI ARABIA

Saudi Arabia Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

UNITED ARAB EMIRATES

UAE Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UAE Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

UAE Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UAE Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

UAE Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UAE Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

UAE Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UAE Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

REST OF MIDDLE EAST

Rest of Middle East Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

AFRICA

miRNA Sequencing and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)

Africa Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Africa Historic Review for miRNA Sequencing and Assays by Product & Service - miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for miRNA Sequencing and Assays by Product & Service - Percentage Breakdown of Value Sales for miRNA Sequencing & Assay Products and miRNA Sequencing & Assay Services for the Years 2015, 2025 & 2030

Africa Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Africa Historic Review for miRNA Sequencing and Assays by Application - Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for miRNA Sequencing and Assays by Application - Percentage Breakdown of Value Sales for Autoimmune Diseases Application, Schizophrenia Application, Other Applications, Cancer Application and Polyglutamine Diseases Application for the Years 2015, 2025 & 2030

Africa Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Africa Historic Review for miRNA Sequencing and Assays by End-Use - Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for miRNA Sequencing and Assays by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes End-Use, Pharma & Biotech Companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

Africa Recent Past, Current & Future Analysis for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Africa Historic Review for miRNA Sequencing and Assays by Technology - Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for miRNA Sequencing and Assays by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis Technology, Sequencing by Oligonucleotide Ligation & Detection (SOLiD) Technology, Nanopore Sequencing Technology, Sanger Sequencing Technology and Single Molecule Real-time (SMRT) Sequencing Technology for the Years 2015, 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *
Abcam Plc	%
Aurora Biomed, Inc.	%
HTG Molecular Diagnostics, Inc.	%
Illumina, Inc.	%
Lexogen	%
Meridian Bioscience, Inc.	%
New England Biolabs, Inc.	%
Norgen Biotek Corp.	%
QIAGEN NV	%
Seegene, Inc.	%

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll